Risk Assessment for Gastrointestinal Diseases via Clinical Dimension and Genome-Wide Polygenic Risk Scores of Type 2 Diabetes: A Population-Based Cohort Study

被引:3
|
作者
Fu, Tian [1 ,2 ,3 ,4 ]
Sun, Yuhao [1 ,2 ,3 ]
Lu, Shiyuan [1 ]
Zhao, Jianhui [2 ,3 ]
Dan, Lintao [2 ,3 ]
Shi, Wenming [5 ]
Chen, Jie [2 ,3 ,4 ]
Chen, Yan [1 ]
Li, Xue [2 ,3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Gastroenterol, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Publ Hlth, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[4] Cent South Univ, Xiangya Hosp 3, Dept Gastroenterol, Changsha, Peoples R China
[5] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Peoples R China
关键词
FATTY LIVER-DISEASE; GASTROESOPHAGEAL-REFLUX DISEASE; ACUTE-PANCREATITIS; MELLITUS; SYMPTOMS; OBESITY;
D O I
10.2337/dc23-0978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE We aimed to evaluate whether individuals with type 2 diabetes (T2D) were at higher risk of developing a wide range of gastrointestinal diseases based on a population-based cohort study. RESEARCH DESIGN AND METHODS This study included 374,125 participants free of gastrointestinal disorders at baseline; of them, 19,719 (5.27%) with T2D were followed-up by linking to multiple medical records to record gastrointestinal disease diagnoses. Multivariable Cox models were used to estimate the hazard ratios (HRs) and CIs. Logistic models were used to examine the associations between polygenic risk scores (PRS) and clinical gastrointestinal phenotypes. RESULTS During amedian follow-up of 12.0 years, we observed the new onset of 15 gastrointestinal diseases. Compared with nondiabetes, participants with T2D had an increased risk of gastritis and duodenitis (HR 1.58, 95% CI 1.51-1.65), peptic ulcer (HR 1.56, 95% CI 1.43-1.71), diverticular disease (HR 1.19, 95% CI 1.14-1.24), pancreatitis (HR 1.45, 95% CI 1.24-1.71), nonalcoholic fatty liver disease (HR 2.46, 95% CI 2.25-2.69), liver cirrhosis (HR 2.92, 95% CI 2.58-3.30), biliary disease (HR 1.18, 95% CI 1.10-1.26), gastrointestinal tract cancers (HR 1.28, 95% CI 1.17-1.40), and hepatobiliary and pancreatic cancer (HR 2.32, 95% CI 2.01-2.67). Positive associations of PRS of T2D with gastritis, duodenitis, and nonalcoholic fatty liver disease were also observed. CONCLUSIONS In this large cohort study, we found that T2D was associated with increased risks of a wide range of gastrointestinal outcomes. We suggest the importance of early detection and prevention of gastrointestinal disorders among patients with T2D.
引用
收藏
页码:418 / 426
页数:9
相关论文
共 50 条
  • [31] Getting the Most Out of Your Genome-Wide Association Study Using Polygenic Risk Scores
    Maggioncalda, Emily
    Snitkin, Evan
    JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (07)
  • [32] Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study
    Lanting, Vincent
    Vago, Emese
    Horvath-Puho, Erzsebet
    Mulder, Frits
    Di Nisio, Marcello
    Kamphuisen, Pieter W.
    Pedersen, Lars
    van Es, Nick
    Sorensen, Henrik T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2025, 23 (02) : 600 - 609
  • [33] Genome-Wide Polygenic Score and the Risk of Ischemic Stroke in a Prospective Cohort The Hisayama Study
    Hachiya, Tsuyoshi
    Hata, Jun
    Hirakawa, Yoichiro
    Yoshida, Daigo
    Furuta, Yoshihiko
    Kitazono, Takanari
    Shimizu, Atsushi
    Ninomiya, Toshiharu
    STROKE, 2020, 51 (03) : 759 - 765
  • [34] Polygenic risk scores for pan-cancer risk prediction in the Chinese population: A population-based cohort study based on the China Kadoorie Biobank
    Zhu, Meng
    Zhu, Xia
    Han, Yuting
    Ma, Zhimin
    Ji, Chen
    Wang, Tianpei
    Yan, Caiwang
    Song, Ci
    Yu, Canqing
    Sun, Dianjianyi
    Jiang, Yue
    Chen, Jiaping
    Yang, Ling
    Chen, Yiping
    Du, Huaidong
    Walters, Robin
    Millwood, Iona Y.
    Dai, Juncheng
    Ma, Hongxia
    Zhang, Zhengdong
    Chen, Zhengming
    Hu, Zhibin
    Lv, Jun
    Jin, Guangfu
    Li, Liming
    Shen, Hongbing
    PLOS MEDICINE, 2025, 22 (02)
  • [35] Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study
    Ho, Peh Joo
    Tan, Iain BeeHuat
    Chong, Dawn Qingqing
    Khor, Chiea Chuen
    Yuan, Jian-Min
    Koh, Woon-Puay
    Dorajoo, Rajkumar
    Li, Jingmei
    Yang, Qifeng
    ELIFE, 2023, 12
  • [36] Risk of type 2 diabetes in patients with insomnia: A population-based historical cohort study
    Lin, Chia-Ling
    Chien, Wu-Chien
    Chung, Chi-Hsiang
    Wu, Fei-Ling
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (01)
  • [37] RISK OF TYPE 2 DIABETES IN PATIENTS WITH INSOMNIA: A POPULATION-BASED RETROSPECTIVE COHORT STUDY
    Wu, F. -L.
    Lin, C. -L.
    Chien, W. -C.
    Chung, C. -H.
    SLEEP MEDICINE, 2017, 40 : E348 - E348
  • [38] Statin therapy and risk of polyneuropathy in type 2 diabetes: A population-based cohort study
    Kristensen, Frederik Pagh
    Christensen, Diana Hedevang
    Callaghan, Brian
    Knudsen, Soren Tang
    Sindrup, Soren H.
    Feldman, Eva L.
    Ostergaard, Leif
    Andersen, Henning
    Jensen, Troels Staehelin
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 62 - 62
  • [39] Statin therapy and risk of polyneuropathy in type 2 diabetes: a population-based cohort study
    Christensen, D. H.
    Kristensen, F. P.
    Callaghan, B. C.
    Knudsen, S. T.
    Sindrup, S. H.
    Feldman, E. L.
    Ostergaard, L.
    Andersen, H.
    Jensen, T. S.
    Sorensen, H. T.
    Thomsen, R. W.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S93 - S94
  • [40] Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study
    Chaker, Layal
    Ligthart, Symen
    Korevaar, Tim I. M.
    Hofman, Albert
    Franco, Oscar H.
    Peeters, Robin P.
    Dehghan, Abbas
    BMC MEDICINE, 2016, 14